BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38730452)

  • 1. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
    Fukihara J; Sakamoto K; Ikeyama Y; Furukawa T; Teramachi R; Kataoka K; Kondoh Y; Hashimoto N; Ishii M
    Respir Res; 2024 May; 25(1):202. PubMed ID: 38730452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
    Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
    Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
    Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis.
    Paplińska-Goryca M; Goryca K; Misiukiewicz-Stępień P; Nejman-Gryz P; Proboszcz M; Górska K; Maskey-Warzęchowska M; Krenke R
    Eur J Clin Invest; 2019 Sep; 49(9):e13153. PubMed ID: 31246273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
    Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
    J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
    Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
    Front Immunol; 2020; 11():562564. PubMed ID: 33101280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis.
    Lee JU; Kim MK; Kim MS; Lee SJ; Park SL; Chang HS; Park JS; Park CS
    J Korean Med Sci; 2024 Jan; 39(1):e13. PubMed ID: 38193329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis.
    Nishikiori H; Chiba H; Ariki S; Kuronuma K; Otsuka M; Shiratori M; Ikeda K; Watanabe A; Kuroki Y; Takahashi H
    BMC Pulm Med; 2014 Dec; 14():196. PubMed ID: 25488319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
    Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.